Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Comparator Study to Assess the Relative Efficacy of Genotypic Versus Virtual Phenotypic Resistance Tests in Treatment Experienced Patients With HIV Infection for Whom a Change in Therapy is Indicated

NCT00262717 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT00262717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00262717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Comparator Study to Assess the Relative Efficacy of Genotypic Versus Virtual Phenotypic Resistance Tests in Treatment Experienced Patients With HIV Infection for Whom a Change in Therapy is Indicated
Lead sponsor
Kirby Institute
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2001
Completion date
July 31, 2006
Enrollment
338 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection